Cargando…
P606: MEASUREMENT OF INTRACLONAL DIVERSIFICATION REFINES THE PROGNOSTIC IMPACT OF IGHV MUTATIONS IN CLL
Autores principales: | Vit, Filippo, Bittolo, Tamara, Papotti, Robel, Pozzo, Federico, Zucchetto, Antonella, Tissino, Erika, Zaina, Eva, Catarossi, Ilaria, Laureana, Roberta, Olivieri, Jacopo, Bulian, Pietro, Levato, Luciano, D’arena, Giovanni, Armiento, Daniele, Zamò, Alberto, Leich, Ellen, Rosenwald, Andreas, Arons, Evgeny, J. Kreitman, Robert, Gentile, Massimo, Laurenti, Luca, Zaja, Francesco, Tafuri, Agostino, Chiarenza, Annalisa, Ilaria DEL Principe, Maria, Gattei, Valter, Bomben, Riccardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429617/ http://dx.doi.org/10.1097/01.HS9.0000969328.93960.3e |
Ejemplares similares
-
TP53 Mutations and Clinical Outcome in Chronic Lymphocytic Leukemia: Is a Threshold Still Needed?
por: Bomben, Riccardo, et al.
Publicado: (2023) -
Follicular lymphoma subgroups with and without t(14;18) differ in their N-glycosylation pattern and IGHV usage
por: Leich, Ellen, et al.
Publicado: (2021) -
S143: NATURAL CLONAL EVOLUTION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH BIMODAL CD49D EXPRESSION REVEALS CD49D PLASTICITY
por: Tissino, Erika, et al.
Publicado: (2023) -
P594: THE CXCR4-LOW/CD5-HIGH PROLIFERATIVE FRACTION IS ENRICHED IN BTK MUTATIONS AND ANTICIPATES RELAPSE IN IBRUTINIB-TREATED CLL
por: Pozzo, Federico, et al.
Publicado: (2023) -
Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study
por: Bomben, Riccardo, et al.
Publicado: (2023)